Product NDC: | 52544-892 |
Proprietary Name: | Jolivette |
Non Proprietary Name: | NORETHINDRONE |
Active Ingredient(s): | .35 mg/1 & nbsp; NORETHINDRONE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52544-892 |
Labeler Name: | Watson Pharma Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA016954 |
Marketing Category: | NDA |
Start Marketing Date: | 20030301 |
Package NDC: | 52544-892-28 |
Package Description: | 6 BLISTER PACK in 1 BOX (52544-892-28) > 28 TABLET in 1 BLISTER PACK |
NDC Code | 52544-892-28 |
Proprietary Name | Jolivette |
Package Description | 6 BLISTER PACK in 1 BOX (52544-892-28) > 28 TABLET in 1 BLISTER PACK |
Product NDC | 52544-892 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | NORETHINDRONE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20030301 |
Marketing Category Name | NDA |
Labeler Name | Watson Pharma Inc |
Substance Name | NORETHINDRONE |
Strength Number | .35 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |